Over the past 10 years, Amos Adler has been focussed on the commercialization, adoption and scale-up of innovative digital health solutions. Having deployed dozens of data-driven patient engagement and support programs in multiple clinical and commercial settings, Amos’s focus has always been creating value from health data. As founder of Memotext and A4i Inc., his focus is on driving ROI through collaborations.
Linda Kaleis is the Lead Data Scientist for Memotext. She is a health informatics professional who completed her Master of Health Informatics at the Institute of Health Policy, Management, and Evaluation at the University of Toronto and holds a certificate in Predictive Analytics from Ryerson University. Her undergraduate background is in cognitive science from McGill University.
Before joining MEMOTEXT as CFO/IR, Milind Parate spent 16 years on Wall Street covering the healthcare sector (therapeutics, services, HCIT) across investment banking (M&A, corporate finance) and equity research. He received an M.Sc. Health Policy, Planning & Financing from the London School of Economics and an A.B. in Economics from the University of Chicago.
With all this blabbering about the shortcomings of the business of adherence, the point is not so much that adherence is not relevant, but that it is often a bloated, overused and misunderstood concept.